Insiders / Drachman Jonathan G
Drachman Jonathan G
CIK 1588467personinsider
Companies
3
First seen
May 7, 2021
Last activity
Mar 11, 2024
Companies
| Company | Shares held | Latest |
|---|---|---|
| Neoleukin Therapeutics, Inc. · NGNE | 2,298,686 | — |
| Calithera Biosciences, Inc. · CALA | 200,000 | — |
| Harpoon Therapeutics, Inc. · HARP | 0 | — |
All securities held
4 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Calithera Biosciences, Inc. | Common stock | 200,000 |
| Neoleukin Therapeutics, Inc. | Common stock | 2,298,686 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Calithera Biosciences, Inc. | Options | 20,000 |
| Neoleukin Therapeutics, Inc. | Options | 350,000 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Aug 24, 2021 | Buy Open-market buy | NGNE Neoleukin Therapeutics, Inc. Common Stock | $611.1K | +100K +4.45% | 2,348,686 11.74% of shares | high |
| Jun 3, 2021 | Buy Open-market buy | NGNE Neoleukin Therapeutics, Inc. Common Stock | $379.3K | +40K +1.82% | 2,238,686 11.19% of shares | medium |
| Nov 10, 2021 | Buy Open-market buy | CALA Calithera Biosciences, Inc. |